ConductScience.org, home

Paper35533682

Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.

Mutlu L and 3 others. Expert Rev Anticancer Ther, 2022. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer. Papers, record 35533682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35533682

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.
PubMed
Journal
Expert Rev Anticancer Ther
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2022-08-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mutlu LLevent
2Tymon-Rosario JJoan
3Harold JJustin
4Menderes GGulden

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Uterine Cervical NeoplasmsMajor topic
Bevacizumab
Female
Humans
Immunotherapy
Neoplasm Recurrence, Local

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42766055Therapy resistance-related ncRNAs in cervical cancer: biomarkers and therapeutic targets.Daru2026https://conductscience.org/library/papers/42766055PubMed
42598864WTAP-Mediated m6A Modification of TXNDC5 mRNA Promotes Cervical Carcinogenesis.Kaohsiung J Med Sci2026https://conductscience.org/library/papers/42598864PubMed
40813953Research on the regulatory effects and mechanisms of YES1 on apoptosis and autophagy in cervical cancer cells.Discov Oncol2025https://conductscience.org/library/papers/40813953PubMed
40667502Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential.Front Pharmacol2025https://conductscience.org/library/papers/40667502PubMed
40434537Exploring program-cell death patterns to predict prognosis and sensitivity of cervical cancer immunotherapy via multi-omics analysis and clinical samples.Discov Oncol2025https://conductscience.org/library/papers/40434537PubMed
40270962Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis.Front Immunol2025https://conductscience.org/library/papers/40270962PubMed
40159879Research hotspots and trends in the field of immune checkpoint inhibitors (ICIs) for cervical cancer: A bibliometric study from 2014 to 2024.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40159879PubMed
39921802Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis.Clin Transl Oncol2025https://conductscience.org/library/papers/39921802PubMed
39856747METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling.Hereditas2025https://conductscience.org/library/papers/39856747PubMed
38970071M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway.Eur J Med Res2024https://conductscience.org/library/papers/38970071PubMed
38903711Progress in the study of antibody-drug conjugates for the treatment of cervical cancer.Front Oncol2024https://conductscience.org/library/papers/38903711PubMed
38892393Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix.Int J Mol Sci2024https://conductscience.org/library/papers/38892393PubMed
38449793Extracellular cancer‑associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor‑promoting roles and prognosis biomarker functions.Oncol Lett2024https://conductscience.org/library/papers/38449793PubMed
38372700M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.Cancer Biol Ther2024https://conductscience.org/library/papers/38372700PubMed
38200479Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis.Cancer Cell Int2024https://conductscience.org/library/papers/38200479PubMed
37664056Clinical analysis of decision implementation by a multidisciplinary team in cervical cancer cases in Ganzhou, China.Front Oncol2023https://conductscience.org/library/papers/37664056PubMed
37060468Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients.Med Oncol2023https://conductscience.org/library/papers/37060468PubMed
36980689Inhibition of IDH3α Enhanced the Efficacy of Chemoimmunotherapy by Regulating Acidic Tumor Microenvironments.Cancers (Basel)2023https://conductscience.org/library/papers/36980689PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35533682

GET https://conductscience.org/api/papers/v1/35533682/authors